Literature DB >> 27413817

Mapping is a prerequisite for elimination of filariasis and effective targeting of filarial 'hot spots'.

Gyan Chand1, Laxman Singh Kaushal1, Narendra Kumar Choudhari1, Neeru Singh2.   

Abstract

OBJECTIVE: This study was undertaken to determine the prevalence of filarial infection in the districts of Madhya Pradesh, which were classified as non-endemic by the national program for control of filariasis. These districts showed evidence of clinical symptoms related to filariasis. To confirm the presence of filariasis, night blood surveys and entomological surveys were carried out to detect microfilaria in humans and filarial infection in vectors.
MATERIALS AND METHODS: For microfilaria surveys, thick blood smears were prepared by taking 60 μL of blood between 8.00 and 11.00 pm and examined under a microscope. Vectors Culex quinquefasciatus were dissected for the filarial infection from the affected villages of four non-endemic districts.
RESULTS: Prevalence of microfilaria in the four districts ranged from 3.8% in district Shivpuri to 11.2% in district Bhind (overall mf rate 6.9%, 95% CI = 6.2-7.7). Infection and infectivity rates among vectors were recorded from three districts which varied from 2 to 13% and from 1.3 to 3.6%.
CONCLUSION: The study confirmed the presence of circulating microfilaria in non-endemic population of four districts, which has significant public health implications. To assess filarial endemicity and hot spots, precise filarial risk mapping using new efficient diagnostic tools is needed to reinforce and extend the strategy in other areas to achieve elimination of lymphatic filariasis.

Entities:  

Keywords:  Filaria elimination; Lymphatic filariasis; Mass drug administration; Wuchereria bancrofti

Mesh:

Year:  2016        PMID: 27413817      PMCID: PMC5072111          DOI: 10.1080/20477724.2016.1205302

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  29 in total

1.  Elimination of lymphatic filariasis in India.

Authors:  S Sabesan; R Ravi; P K Das
Journal:  Lancet Infect Dis       Date:  2005-01       Impact factor: 25.071

2.  Lymphatic filariasis: progress of disability prevention activities.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2004-11-19

3.  Antigenemia in young children living in Wuchereria bancrofti-endemic areas of Orissa, India.

Authors:  M S Bal; M K Beuria; N N Mandal; M K Das
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-09-21       Impact factor: 2.184

4.  Prevalence of Wuchereria bancrofti infection among the tribals of Panna district of Madhya Pradesh.

Authors:  G Chand; G D Pandey; R S Tiwary
Journal:  J Commun Dis       Date:  1996-12

5.  Mapping of lymphatic filariasis in India.

Authors:  S Sabesan; M Palaniyandi; P K Das; E Michael
Journal:  Ann Trop Med Parasitol       Date:  2000-09

6.  A survey of bancroftian filariasis for microfilariae & circulating antigenaemia in two villages of Madhya Pradesh.

Authors:  D Das; S Kumar; P K Sahoo; A P Dash
Journal:  Indian J Med Res       Date:  2005-06       Impact factor: 2.375

7.  Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.

Authors:  K D Ramaiah; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

8.  The Elimination of Lymphatic Filariasis: A Strategy for Poverty Alleviation and Sustainable Development - Perspectives from the Philippines.

Authors:  Jaime Z Galvez Tan
Journal:  Filaria J       Date:  2003-07-21

Review 9.  Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status.

Authors:  T Jacob John; Vipin M Vashishtha
Journal:  Indian J Med Res       Date:  2013-05       Impact factor: 2.375

10.  Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood.

Authors:  Gary J Weil; Kurt C Curtis; Lawrence Fakoli; Kerstin Fischer; Lincoln Gankpala; Patrick J Lammie; Andrew C Majewski; Sonia Pelletreau; Kimberly Y Won; Fatorma K Bolay; Peter U Fischer
Journal:  Am J Trop Med Hyg       Date:  2013-05-20       Impact factor: 2.345

View more
  3 in total

1.  Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia.

Authors:  D Ramaiah Kapa; Ahmed Jamsheed Mohamed
Journal:  Int Health       Date:  2020-12-22       Impact factor: 2.473

2.  Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.

Authors:  Abdul Mabood Khan
Journal:  Indian J Med Res       Date:  2018-01       Impact factor: 2.375

3.  Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.

Authors:  Corrado Minetti; Edward J Tettevi; Frank Mechan; Joaquín M Prada; Bright Idun; Nana-Kwadwo Biritwum; Mike Yaw Osei-Atweneboana; Lisa J Reimer
Journal:  PLoS Negl Trop Dis       Date:  2019-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.